Shlaes D M, Gerding D N, John J F, Craig W A, Bornstein D L, Duncan R A, Eckman M R, Farrer W E, Greene W H, Lorian V, Levy S, McGowan J E, Paul S M, Ruskin J, Tenover F C, Watanakunakorn C
Wyeth-Ayerst Research, Pearl River, NY 10965, USA.
Infect Control Hosp Epidemiol. 1997 Apr;18(4):275-91. doi: 10.1086/647610.
Antimicrobial resistance results in increased morbidity, mortality, and costs of health care. Prevention of the emergence of resistance and the dissemination of resistant microorganisms will reduce these adverse effects and their attendant costs. Appropriate antimicrobial stewardship that includes optimal selection, dose, and duration of treatment, as well as control of antibiotic use, will prevent or slow the emergence of resistance among microorganisms. A comprehensively applied infection control program will interdict the dissemination of resistant strains.
抗菌药物耐药性导致发病率、死亡率上升以及医疗保健成本增加。预防耐药性的出现和耐药微生物的传播将减少这些不良影响及其带来的成本。适当的抗菌药物管理,包括优化治疗的选择、剂量和疗程,以及控制抗生素的使用,将预防或减缓微生物耐药性的出现。全面实施的感染控制计划将阻断耐药菌株的传播。